Electrocardiographic QRS Axis Shift ,Rotation and COVİD-19

NCT04698083 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2021-01-06

No results posted yet for this study

Summary

In patients with coronavirus disease (COVID-19), severe dyspnea is the most dramatic complication.Severe respiratory difficulties may include electrocardiographic frontal QRS axis rightward shift (Rws) and clockwise rotation (Cwr).

This study investigated the predictability of advanced lung tomography findings with QRS axis shift and rotation.

This was a retrospective analysis of 160 patients.The patients were divided into two groups: normal oxygen saturation(SpO2) (NS; n = 80) and low SpO2(LS;n = 80).They were then divided into NS Rws (n = 37), NS leftward shift (Lws; n = 43), LS Rws (n = 40), and LS Lws (n = 40) according to electrocardiographic follow-up findings. These groups were compared in terms of electrocardiographic rotation (Cwr, counterclockwise rotation, or normal transition), tomographic stage (CO-RADS5(advanced)/CO-RADS1-4), electrocardiographic intervals, and laboratory findings

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

Electrocardiography ,Tomographic imaging

Based on electrocardiographic follow-up analyses,the two main groups were compared in terms of rotation condition (i.e., Cwr, normal transition, or CCwr), electrocardiographic intervals, and laboratory findings In our study,CO-RADS5 was considered an advanced tomographic finding(e.g., multifocal ground glass opacities with consolidation, vascular thickening,crazy paving pattern,mixed pattern),while CO-RADS1,2,3, and 4 were considered non-advanced tomographic findings.

Sponsors & Collaborators

  • Ankara Education and Research Hospital

    lead OTHER_GOV

Principal Investigators

  • Şahbender Koç · University of Health Sciences Ankara Keçiören Education Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-22
Primary Completion
2020-10-15
Completion
2020-11-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04698083 on ClinicalTrials.gov